Evaluation of Scientific Publications on Osteoblastoma Published between 2000 and 2022

Selçuk YILMAZ, Mehmet KURT
{"title":"Evaluation of Scientific Publications on Osteoblastoma Published between 2000 and 2022","authors":"Selçuk YILMAZ, Mehmet KURT","doi":"10.16899/jcm.1317474","DOIUrl":null,"url":null,"abstract":"Objective: The aim of this bibliometric study was to review the scientific outputs published between 2000 and 2022 on osteoblastoma, a benign aggressive bone tumor.
 Methods: Scientific research articles on osteoblastoma published between 2000 and 2022 were targeted and data were obtained from the Web of Science database. The data obtained were analyzed and visualized using bibliometric programs.
 Results: A total of 679 articles about osteoblastoma published between 2000-2022 met our inclusion criteria. Most of the articles on osteoblastoma (n=48) were published in 2020. There was no noteworthy peak in the trend of the number of publications between 2000 and 2022. These articles cited 10366 times in total and 15.27 times per article. At least 62 various countries and regions took part in osteoblastoma publishing research over the past 22 years. The United States (192) was the largest contributor to osteoblastoma publications followed by China (60), India (51), Italy (50), and Turkey (46). The United States was the country that published the most publications in all years between 2000 and 2022. Especially China's publications increased in 2022. The United States was also the country with the highest level of publication collaboration (such as citation and co-authorship) among countries.
 Conclusion: The number of published articles is well below the expected level. Although the number of scientific publications from China has increased in recent years, the United States still ranks first.","PeriodicalId":15449,"journal":{"name":"Journal of contemporary medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of contemporary medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.16899/jcm.1317474","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The aim of this bibliometric study was to review the scientific outputs published between 2000 and 2022 on osteoblastoma, a benign aggressive bone tumor. Methods: Scientific research articles on osteoblastoma published between 2000 and 2022 were targeted and data were obtained from the Web of Science database. The data obtained were analyzed and visualized using bibliometric programs. Results: A total of 679 articles about osteoblastoma published between 2000-2022 met our inclusion criteria. Most of the articles on osteoblastoma (n=48) were published in 2020. There was no noteworthy peak in the trend of the number of publications between 2000 and 2022. These articles cited 10366 times in total and 15.27 times per article. At least 62 various countries and regions took part in osteoblastoma publishing research over the past 22 years. The United States (192) was the largest contributor to osteoblastoma publications followed by China (60), India (51), Italy (50), and Turkey (46). The United States was the country that published the most publications in all years between 2000 and 2022. Especially China's publications increased in 2022. The United States was also the country with the highest level of publication collaboration (such as citation and co-authorship) among countries. Conclusion: The number of published articles is well below the expected level. Although the number of scientific publications from China has increased in recent years, the United States still ranks first.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2000年至2022年间发表的成骨细胞瘤科学出版物的评价
目的:本文献计量学研究的目的是回顾2000年至2022年间发表的关于成骨细胞瘤(一种良性侵袭性骨肿瘤)的科学成果。方法:选取2000 - 2022年间发表的成骨细胞瘤相关的科研论文,数据来源于Web of Science数据库。使用文献计量学程序对获得的数据进行分析和可视化。 结果:2000-2022年间发表的关于成骨细胞瘤的679篇文章符合我们的纳入标准。大多数关于成骨细胞瘤的文章(48篇)发表于2020年。在2000年至2022年期间,出版物数量的趋势没有明显的峰值。总被引次数10366次,平均被引次数15.27次。在过去的22年中,至少有62个不同的国家和地区参与了成骨细胞瘤的出版研究。美国(192)是发表成骨细胞瘤论文最多的国家,其次是中国(60)、印度(51)、意大利(50)和土耳其(46)。在2000年至2022年期间,美国是出版出版物最多的国家。特别是中国的出版物在2022年有所增加。美国也是各国中出版合作(如引文和合著)水平最高的国家。 结论:论文发表数量远低于预期水平。尽管近年来中国的科学出版物数量有所增加,但美国仍然排名第一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The association between six-minute walk test and one minute sit to stand test in patients with acute exacerbations of COPD INVESTIGATION OF THE ADJECTIVES IN TERMINOLOGIA ANATOMICA, IN TERMS RELATED TO THE NERVOUS SYSTEM AND SENSE ORGANS Smoking and Real Life Results of Children and Adolescents Correlation of Capillary Tube and Transcutaneous Methods with Serum Biochemistry in Bilirubin Levels in Neonates with Jaundice Current follow-up results of Cyanotic Congenital Heart Diseases detected during Pregnancy in a specific Region
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1